nisoldipine has been researched along with Puerperal Disorders in 1 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The calcium antagonist nisoldipine (Bayer-Miles) was given orally (20 mg, 8-hourly) in the management of 12 selected cases of severe postpartum pregnancy-induced hypertension (PIH)." | 9.07 | Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results. ( Belfort, MA; Kirshon, B, 1992) |
| "The calcium antagonist nisoldipine (Bayer-Miles) was given orally (20 mg, 8-hourly) in the management of 12 selected cases of severe postpartum pregnancy-induced hypertension (PIH)." | 5.07 | Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results. ( Belfort, MA; Kirshon, B, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belfort, MA | 1 |
| Kirshon, B | 1 |
1 trial available for nisoldipine and Puerperal Disorders
| Article | Year |
|---|---|
Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results.
Topics: Blood Pressure; Female; Heart Rate; Humans; Hypertension; Nisoldipine; Pilot Projects; Pregnancy; Pu | 1992 |